not tagged
daiichi sankyo
[]
every patient is unique and so are their needs. despite the significant progress that has been made in oncology research, there remains areas of unmet needs. #asco22 
This channel is provided by the pharmaceutical company Daiichi Sankyo Europe GmbH. Imprint: https://t.co/wShbXmrDQo Guidelines: https://t.co/fPbp6jZ1nx